| Robert E Fox, MD | |
|
268 Post Rd, Suite 203, Westerly, RI 02891-6600 | |
| (401) 604-2530 | |
| (401) 604-2560 |
| Full Name | Robert E Fox |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 32 Years |
| Location | 268 Post Rd, Westerly, Rhode Island |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003853268 | NPI | - | NPPES |
| P00015916 | Other | RI | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD09837 (Rhode Island) | Primary |
| 207RA0000X | Internal Medicine - Adolescent Medicine | RI9837 (Rhode Island) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South County Home Health | Narragansett, RI | Home health agency |
| Bayada Home Health Care, Inc | Providence, RI | Home health agency |
| Beacon Hospice, An Amedisys Company | East providence, RI | Hospice |
| South County Hospital Inc | Wakefield, RI | Hospital |
| Westerly Hospital | Westerly, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Silver Spring Health Care Management Inc | 4688661127 | 118 |
| Ptsma Inc | 7911800180 | 92 |
News Archive
According to the United States Department of Health and Human Services' Healthy People 2010 objectives, adequate fruit and vegetable consumption is a national public health priority for disease prevention and maintenance of good health.
In a large clinical trial, nilotinib demonstrated greater efficacy over the current gold standard treatment, imatinib, in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML) in the chronic phase.
TxCell SA, a biotechnology company developing innovative, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, today announces that activity and tolerance data for its second lead product Col-Treg were presented through a poster presentation at the 2015 ARVO Annual Meeting, May 3-7, 2015, in Denver, Colorado, US.
Cholera has been confirmed as the cause of death of 16 persons on a remote island in Papua New Guinea which is close to Australia's maritime border. The first case was detected on Daru Island in Western Province three weeks ago. Since then 12 adults and 4 children have died, and 320 others have been treated for the infection.
Medivir AB, announced today that it has acquired preclinical research stage assets from Novadex Pharmaceuticals AB. The acquisition includes intellectual property and prodrug technologies in order to further strengthen Medivir's hepatitis C platform and know how.
› Verified 8 days ago
| Entity Name | Silver Spring Health Care Management Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306365812 PECOS PAC ID: 4688661127 Enrollment ID: O20180214001403 |
News Archive
According to the United States Department of Health and Human Services' Healthy People 2010 objectives, adequate fruit and vegetable consumption is a national public health priority for disease prevention and maintenance of good health.
In a large clinical trial, nilotinib demonstrated greater efficacy over the current gold standard treatment, imatinib, in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML) in the chronic phase.
TxCell SA, a biotechnology company developing innovative, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, today announces that activity and tolerance data for its second lead product Col-Treg were presented through a poster presentation at the 2015 ARVO Annual Meeting, May 3-7, 2015, in Denver, Colorado, US.
Cholera has been confirmed as the cause of death of 16 persons on a remote island in Papua New Guinea which is close to Australia's maritime border. The first case was detected on Daru Island in Western Province three weeks ago. Since then 12 adults and 4 children have died, and 320 others have been treated for the infection.
Medivir AB, announced today that it has acquired preclinical research stage assets from Novadex Pharmaceuticals AB. The acquisition includes intellectual property and prodrug technologies in order to further strengthen Medivir's hepatitis C platform and know how.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert E Fox, MD Po Box 229, Wakefield, RI 02880-0229 Ph: (401) 788-3929 | Robert E Fox, MD 268 Post Rd, Suite 203, Westerly, RI 02891-6600 Ph: (401) 604-2530 |
News Archive
According to the United States Department of Health and Human Services' Healthy People 2010 objectives, adequate fruit and vegetable consumption is a national public health priority for disease prevention and maintenance of good health.
In a large clinical trial, nilotinib demonstrated greater efficacy over the current gold standard treatment, imatinib, in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML) in the chronic phase.
TxCell SA, a biotechnology company developing innovative, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, today announces that activity and tolerance data for its second lead product Col-Treg were presented through a poster presentation at the 2015 ARVO Annual Meeting, May 3-7, 2015, in Denver, Colorado, US.
Cholera has been confirmed as the cause of death of 16 persons on a remote island in Papua New Guinea which is close to Australia's maritime border. The first case was detected on Daru Island in Western Province three weeks ago. Since then 12 adults and 4 children have died, and 320 others have been treated for the infection.
Medivir AB, announced today that it has acquired preclinical research stage assets from Novadex Pharmaceuticals AB. The acquisition includes intellectual property and prodrug technologies in order to further strengthen Medivir's hepatitis C platform and know how.
› Verified 8 days ago
Dr. James G Stuart, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 46 Wells Street, Westerly, RI 02891 Phone: 401-596-0174 Fax: 401-596-2266 | |
Mr. Christopher A. D'arcy, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 45 Wells Street, Suite 203b, Westerly, RI 02891 Phone: 401-348-2180 Fax: 401-348-6298 | |
Joseph R Dotolo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 27 Crestview Dr, Westerly, RI 02891 Phone: 401-596-2277 Fax: 401-596-6140 | |
Dr. Stephen M Kutz, M.D., FACC Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 45 Wells St, Suite 102, Westerly, RI 02891 Phone: 401-596-4499 Fax: 401-596-6360 | |
Vindhya Bharathi Sriramoju, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 45 Wells St Ste 102, Westerly, RI 02891 Phone: 401-596-4499 | |
Peter E. Bolton, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 77 Franklin St, Westerly, RI 02891 Phone: 401-596-6464 Fax: 401-348-8660 |